Gestational diabetes mellitus (GDM) is a significant health concern that affects up to 14% of pregnancies, posing risks to both mother and fetus. Effective management is key to optimizing maternal and fetal outcomes.
Early detection and diagnosis of GDM are crucial for initiating proper management. Universal screening, employing oral glucose tolerance tests, is recommended between 24 and 28 weeks of gestation. For high-risk women, early screening during the first trimester is recommended.
Dietary intervention remains a cornerstone in GDM management. A balanced diet, low in simple sugars and high in complex carbohydrates and fiber, is recommended. Regular dietetic consultation can aid in individualizing nutritional plans and ensuring adherence.
Physical activity can improve glucose control in GDM. Moderate-intensity exercise, unless contraindicated, is recommended. Exercise plans should be individualized and adjusted according to maternal tolerance and fetal response.
If lifestyle modifications are insufficient, pharmacological treatment is indicated. Insulin therapy is the gold standard. However, oral hypoglycemic agents like metformin and glyburide are increasingly being used due to their convenience and cost-effectiveness.
Postpartum follow-up is essential as GDM increases the risk of type 2 diabetes. Glucose tolerance testing should be performed 6-12 weeks postpartum and subsequently every 1-3 years.
In conclusion, GDM management requires a multidisciplinary approach encompassing early detection, dietary modifications, physical activity, pharmacological treatment, and postpartum follow-up. Through comprehensive care, we can effectively optimize maternal and fetal outcomes in GDM.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation